Related Experiment Video
Updated: Jun 12, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study
Orbelina de Palma1, Lilian Cruz, Hector Ramos
1Ministerio de Salud, San Salvador, El Salvador.
Insights
A monovalent rotavirus vaccine demonstrated high effectiveness (76%) against severe rotavirus diarrhea in young children in El Salvador. The vaccine also significantly reduced overall diarrhea hospital admissions in this low-middle income country.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Public health epidemiology
Background:
- Rotavirus is a leading cause of severe diarrheal disease in infants globally.
- El Salvador, a low-middle income country, introduced a monovalent rotavirus vaccine nationally.
- Assessing vaccine effectiveness is crucial for public health policy in resource-limited settings.
Purpose of the Study:
- To evaluate the effectiveness of a monovalent rotavirus vaccine against severe rotavirus disease in children under 2 years old.
- To assess the vaccine's impact on overall diarrhea hospitalizations following its national introduction in El Salvador.
- To analyze vaccine effectiveness by age group and dose received.
Main Methods:
- A matched case-control study was conducted involving 323 children with confirmed rotavirus diarrhea and 969 healthy controls.
- Data were collected from seven hospitals in El Salvador between January 2007 and June 2009.
- Vaccine effectiveness was calculated using adjusted odds ratios, with subgroup analyses by age and number of doses.
Main Results:
- Two doses of the monovalent rotavirus vaccine showed 76% effectiveness against rotavirus diarrhea requiring hospital admission.
- Effectiveness was higher in younger children (6-11 months: 83%) compared to older children (12+ months: 59%).
- One dose demonstrated 51% effectiveness, and overall diarrhea admissions in children under 5 decreased by 40-51% post-vaccination.
Conclusions:
- The monovalent rotavirus vaccine is highly effective in preventing severe rotavirus diarrhea and reducing hospital admissions in young children in El Salvador.
- The substantial reduction in diarrhea admissions highlights the vaccine's significant public health impact in a low-middle income country.
- Further investigation into the vaccine's impact on disease epidemiology, especially in older children, is warranted.
Objective:
To evaluate the effectiveness of a monovalent rotavirus vaccine against severe rotavirus disease and to assess its impact on diarrhoea in children aged less than 2 years after national introduction in El Salvador, a low-middle income country in Central America.
Design:
Matched case-control study.
Setting:
Seven hospitals in cities across El Salvador, January 2007 to June 2009.
Participants:
323 children aged less than 2 years admitted with laboratory confirmed rotavirus diarrhoea and 969 healthy controls matched for age and neighbourhood.
Main Outcome Measure:
Effectiveness of rotavirus vaccination ((1-adjusted odds ratio of vaccination)x100) against rotavirus diarrhoea requiring hospital admission.
Results:
Cases and controls were similar for breast feeding, premature birth, maternal education, and socioeconomic variables. G1P[8] strains were identified in 92% of rotavirus cases. Effectiveness of two doses of vaccination against diarrhoea requiring hospital admission was 76% (95% confidence interval 64% to 84%). Protection was significantly lower (P=0.046) among children aged 12 months or more (59%, 27% to 77%) compared with children aged 6-11 months (83%, 68% to 91%). One dose of vaccine was 51% (26% to 67%) effective. At the sentinel hospitals, all admissions for diarrhoea among children under 5 declined by 40% in 2008 and by 51% in 2009 from the prevaccine year 2006.
Conclusions:
A monovalent rotavirus vaccine was highly effective against admissions for rotavirus diarrhoea in children aged less than 2 years in El Salvador and substantially reduced the number of such admissions in this low-middle income setting. The impact on disease epidemiology after vaccination, particularly among older children, warrants future attention.
Related Concept Videos
Poliomyelitis
Respiratory Syncytial Virus Disease
Cholera
Bacterial Gastroenteritis
Vaccinations
